- Home
- Supplements
- Hyaluronic Acid
- Skin Health Enhancement
Hyaluronic Acid for Skin Health Enhancement
Reasonable short-term evidence for hydration and elasticity, weaker for lasting structural change.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 120-240 mg/day oral hyaluronic acid with food, for at least 8-12 weeks; topically, apply to damp skin twice daily
- Expected timeframe
- 4-12 weeks
Protocol
- form
- Oral low molecular weight HA (under 50 kDa) for systemic use; topical serums work by a different mechanism, drawing water into the stratum corneum
- duration
- 8-12 weeks orally; topical effects are immediate but superficial
- co factor
- Take oral HA with food; apply topical HA to damp skin and seal with a moisturiser, since on dry skin in low humidity it can draw water out of deeper layers and worsen dryness. Evidence is mixed but not weak on the hydration component. Randomised placebo-controlled trials of oral HA at 120-240 mg/day for 8-12 weeks show improved skin moisture content, and some report better elasticity and reduced wrinkle depth, with a systematic review concluding the hydration effect is reasonably consistent. Broader skin health claims - texture, tone, barrier function, acne - are not supported. Several trials are manufacturer-funded and sample sizes are small.
- titration
- Up to 240 mg/day orally
- starting dose
- 120 mg/day orally with food, or apply a topical HA serum to damp skin twice daily
Evidence
What the studies say
No studies are yet linked to both Hyaluronic Acid and Skin Health Enhancement.
Safety
Caveats
Sun protection and not smoking do more for skin than any oral supplement, and topical retinoids have far stronger evidence for texture and fine lines. Persistent dry, itchy skin can indicate eczema, psoriasis, hypothyroidism, iron deficiency or diabetes - worth assessing. Safety: oral HA is well tolerated at 120-240 mg/day over months in trials, with no established upper intake level and no long-term data beyond about a year. Some products come from rooster comb - avoid with egg or poultry allergy. Avoid in active cancer without oncology advice, given HA role in angiogenesis and CD44 signalling. No safety data in pregnancy or breastfeeding - avoid oral supplementation in both, though topical HA is generally considered fine. Injectable HA fillers are a separate intervention with vascular occlusion and infection risks, and require a qualified practitioner.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.